Stay updated with breaking news from Aapge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) shares were down 4.6% during trading on Thursday . The company traded as low as $20.66 and last traded at $20.67. Approximately 64,569 shares changed hands during trading, a decline of 68% from the average daily volume of 202,654 shares. The stock had previously closed at $21.67. […]
Apogee Therapeutics (NASDAQ:APGE – Get Free Report)‘s stock had its “outperform” rating restated by equities research analysts at William Blair in a report released on Monday, RTT News reports. They presently have a $40.00 price objective on the stock. William Blair’s target price suggests a potential upside of 70.21% from the stock’s previous close. A […]
Apogee Therapeutics (NASDAQ:APGE – Get Free Report) announced its quarterly earnings results on Monday. The company reported ($3.78) EPS for the quarter, missing analysts’ consensus estimates of ($2.49) by ($1.29), MarketWatch Earnings reports. Apogee Therapeutics Price Performance APGE opened at $23.50 on Wednesday. Apogee Therapeutics has a 1-year low of $19.98 and a 1-year high […]
Apogee Therapeutics (NASDAQ:APGE – Get Free Report) released its earnings results on Monday. The company reported ($3.78) EPS for the quarter, missing analysts’ consensus estimates of ($2.49) by ($1.29), MarketWatch Earnings reports. Apogee Therapeutics Trading Up 0.4 % Shares of Apogee Therapeutics stock traded up $0.09 on Wednesday, hitting $23.59. 30,420 shares of the company […]
Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) have been given a consensus recommendation of “Buy” by the six analysts that are currently covering the firm, MarketBeat.com reports. Six analysts have rated the stock with a buy rating. The average twelve-month target price among brokerages that have issued ratings on the stock in […]